Skip to content
SPECIFICTION
Get listed

Chemistry42

By Insilico Medicine · pharma.ai

Web
Visit pharma.ai
Spec score 6.9 #6 of 33 in AI Drug Discovery Software

Spec sheet

Purpose
Chemistry42 is a small-molecule drug discovery platform for hit identification, hit-to-lead, and lead optimization.Read 14 Nov 2026 · pharma.ai
Support
The terms say Insilico will use reasonable commercial efforts to host, support, and maintain the subscription.Read 14 Nov 2026 · pharma.ai
ADMET and selectivity
Predictive models profile and optimize ADMET and selectivity, including as standalone tools or within generative experiments.Read 14 Nov 2026 · pharma.ai
Audience and access
The page has a dedicated offering for academia and startups, and links to sign up and log in through Chemistry42 Cloud.Read 14 Nov 2026 · pharma.ai
Binding free energy
Alchemistry computes relative protein-ligand binding free energy to help prioritize lead compounds.Read 14 Nov 2026 · pharma.ai
Building blocks
The retrosynthesis tool includes a collection of 300,000 commercially available building blocks.Read 14 Nov 2026 · pharma.ai
Concurrency limit
Tokens govern how many experiments users in an organization can run simultaneously; token requirements vary by experiment settings.Read 14 Nov 2026 · pharma.ai
Data hosting
The privacy policy states SaaS data is processed in Seoul for cloud.chemistry42.com subscriptions and in Ireland for lab.chemistry42.com subscriptions.Read 14 Nov 2026 · pharma.ai
External tools
The platform can be customized with external QSAR models, MD simulators, and in-house databases.Read 14 Nov 2026 · pharma.ai
Generative chemistry
The platform supports de novo design, hit optimization, scaffold hopping, and R-group search.Read 14 Nov 2026 · pharma.ai
Model training
Users can train predictive models on their own data, including in vitro activity or simulation data.Read 14 Nov 2026 · pharma.ai
Molecular dynamics
MDFlow provides simulation workflows for biomolecules and complexes, from system building and sampling through reporting.Read 14 Nov 2026 · pharma.ai
Retrosynthesis
It predicts synthetic routes for uploaded or generated molecular structures using expert-annotated reaction templates.Read 14 Nov 2026 · pharma.ai
Security caveat
The privacy policy says the company uses commercially acceptable protective measures but cannot guarantee absolute security.Read 14 Nov 2026 · pharma.ai
Subscription use
The terms limit subscription use to internal drug discovery by the customer organization and its affiliates.Read 14 Nov 2026 · pharma.ai

Where Specifiction places it

Alternatives to Chemistry42All alternatives →